Clinical Trial Update: Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and effects of SLx-2101 taken up to 14 days on blood pressure in patients with hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• SLx-2101

Snippet

Sponsor: Response Pharmaceuticals | Conditions: Hypertension | Phase 2 | Status: COMPLETED